
Over the last 7 days, the United States market has remained flat, yet it is up 17% over the past year with earnings forecasted to grow by 18% annually. In this environment, dividend stocks offering yields of up to 5% can be appealing for investors seeking both income and potential growth.
| Name | Dividend Yield | Dividend Rating |
| PNC Financial Services Group (PNC) | 3.20% | ★★★★★☆ |
| Peoples Bancorp (PEBO) | 4.25% | ★★★★★☆ |
| OTC Markets Group (OTCM) | 5.66% | ★★★★★★ |
| Huntington Bancshares (HBAN) | 3.41% | ★★★★★☆ |
| First Interstate BancSystem (FIBK) | 4.82% | ★★★★★★ |
| Ennis (EBF) | 4.71% | ★★★★★★ |
| Donegal Group (DGIC.A) | 4.15% | ★★★★★★ |
| Columbia Banking System (COLB) | 4.51% | ★★★★★★ |
| Bladex (BLX) | 4.64% | ★★★★★☆ |
| Accenture (ACN) | 4.63% | ★★★★★★ |
Click here to see the full list of 89 stocks from our Top US Dividend Stocks screener.
Here we highlight a subset of our preferred stocks from the screener.
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Futu Holdings Limited provides digitalized securities brokerage and wealth management product distribution services in Hong Kong and internationally, with a market cap of approximately $13.78 billion.
Operations: Futu Holdings Limited generates revenue primarily from its online brokerage services and margin financing services, amounting to HK$22.31 billion.
Dividend Yield: 5%
Futu Holdings recently began paying dividends, making it premature to assess their reliability or growth. However, the dividend payout is well-covered by earnings and cash flows, with a low payout ratio of 24.9% and a cash payout ratio of 14%. Despite offering a top-tier dividend yield of 5.01%, Futu faces significant regulatory challenges in China, including proposed penalties totaling approximately US$271 million, which have impacted its stock price and financial results.
Simply Wall St Dividend Rating: ★★★★★☆
Overview: Medtronic plc develops, manufactures, and sells device-based medical therapies globally to healthcare systems, physicians, clinicians, and patients with a market cap of approximately $106.61 billion.
Operations: Medtronic's revenue segments include Neuroscience at $10.29 billion, Cardiovascular at $13.98 billion, and Medical Surgical at $8.82 billion.
Dividend Yield: 3.4%
Medtronic's dividends have been stable and growing over the past decade, with a reliable yield of 3.45%. The company's payout ratios indicate sustainability, with earnings covering 75.8% and cash flows covering 67% of dividend payments. Recent developments include FDA clearance for new medical devices and strategic partnerships expanding its product portfolio, though these are accompanied by some product recalls. Medtronic remains a significant player in dividend stocks despite challenges in maintaining top-tier yields.
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Vipshop Holdings Limited operates online platforms in the People's Republic of China and has a market cap of $7.01 billion.
Operations: Vipshop Holdings Limited's revenue segments include online retail sales of CN¥117.06 billion and logistics services generating CN¥1.54 billion.
Dividend Yield: 4.2%
Vipshop Holdings has demonstrated strong earnings growth, with a 7.5% annual increase over five years, supporting its dividend sustainability. The company maintains a low payout ratio of 28.4%, ensuring dividends are well covered by earnings and cash flows (37.3%). Despite paying dividends for only two years, its yield of 4.22% ranks in the top 25% among US dividend payers. However, forecasted revenue declines may impact future performance as it trades at significant value below fair estimates.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com